ValiRx PLC

ValiRx PLC
Stock Exchange London Stock Exchange
EPS
GBP0.01
Market Cap
GBP1.26 M
Shares Outstanding
454.96 M
Public Float
434.54 M

Profile

Address
16 Upper Woburn Place
London Greater London WC1H 0BS
United Kingdom
Employees -
Website http://www.valirx.com
Updated 07/08/2019
ValiRx Plc operates as a biopharmaceutical company which engages in the development of novel technologies and products in oncology therapeutics and diagnostics. The company products focuses on the epigenomic analysis and treatment of cancer, as well as the technologies can be also applied in other fields, such as neurology and inflammatory diseases. It operates through the Drug Development and Sale of Self-Test Drug Kits segments.

Financials

View All
Created with Highcharts 5.0.14ValiRx PLCNet Income. Fiscal year is January-December. All values GBP Thousands.2 5972 5973 1603 1601 7911 7914 9304 9303 0193 0194 2984 29820132014201520162017201801k2k3k4k5k6k
Created with Highcharts 5.0.14ValiRx PLCSales/Revenue. Fiscal year is January-December. All values GBP Thousands.12412487870000001431432013201420152016201720180255075100125150175

Oliver de Giorgio-Miller
Non-Executive Chairman
Satu Vainikka
Chief Executive Officer & Director